chr16-66517207-G-C
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5
The NM_004614.5(TK2):āc.547C>Gā(p.Arg183Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000547 in 1,461,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004614.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251488Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135920
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461794Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727206
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mitochondrial disease Pathogenic:1
TK2 Arg183Gly (c.547C>G) is a missense variant that changes the amino acid at residue 183 from Arginine to Glycine. It is also described as R152G and R225G in the literature. This variant has been observed in multiple probands affected with mitochondrial disease in the compound heterozygous state, with a pathogenic or likely pathogenic variant confirmed in trans in at least one proband (PMID:38544965;19125351;29602790;12655576). Experimental studies showed reduced activity, however, the significance of this finding remains unclear (19154348). This variant is not present at a significant frequency in gnomAD, and in silico models agree that this variant is possibly or probably damaging. In conclusion, we classify TK2 Arg183Gly (c.547C>G) as a likely pathogenic variant. -
not provided Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 183 of the TK2 protein (p.Arg183Gly). This variant is present in population databases (rs137886900, gnomAD 0.002%). This missense change has been observed in individuals with TK2-related conditions (PMID: 12655576, 12682338, 29602790). This variant is also known as R152G. ClinVar contains an entry for this variant (Variation ID: 38991). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt TK2 protein function with a positive predictive value of 95%. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the p.Arg183 amino acid residue in TK2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15907288, 18819985, 29602790). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at